Article Text

Download PDFPDF

AB0043 TLR4 inhibition reduces movement-induced nociception and ATF-3 expression in experimental osteoarthritis
  1. J Ferreira-Gomes1,2,3,
  2. MM Garcia4,
  3. D Nascimento1,2,3,
  4. L Almeida1,2,3,
  5. E Quesada5,
  6. C Goicoechea4,
  7. J Castro-Lopes1,2,3,
  8. F Neto1,2,3
  1. 1Departamento de Biomedicina – Unidade de Biologia Experimental, Faculdade de Medicina da Universidade do Porto
  2. 2Instituto de Investigação e Inovação em Saúde, Universidade do Porto
  3. 3IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal
  4. 4Area de Farmacologia, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos. Unidad Asociada URJC- IQM-CSIC, Alcorcon
  5. 5Instituto de Química Médica, Consejo Superior de Investigaciones Científicas. Unidad Asociada URJC- IQM-CSIC, Madrid, Spain


Background Toll-like receptor 4 (TLR4) is a pattern recognition receptor involved in the initiation of inflammatory responses to control pathogen infections, but is also a “danger-sensing” receptor that recognizes host-derived endogenous molecules called damage-associated molecular patterns (DAMPs). The role of TLR4 in rheumatic diseases is becoming evident, as well as its potential role as a therapeutic option.

Objectives The aim of this study was to evaluate the effect, both on articular histopathology and pain behaviour, of a TLR4 antagonist (TLR4-A1) on an experimental model of OA. The effect of the TLR4-A1 on the activating transcription factor-3 (ATF-3) signalling pathway was also assessed.

Methods OA was induced in adult Wistar rats through an intra-articular injection of 2mg of sodium mono-iodoacetate (MIA) into the left knee. Control animals received a similar injection with saline. TLR4-A1 (10 mg/kg), synthesized by Dr. Quesada from a compound previously described by the Peri Laboratory (Piazza et al., 2009), was intraperitoneally administered, daily, from days 14 to 28 after OA induction. Under the same procedure a control group of animals received the vehicle. Movement- and loading- induced nociception was evaluated in all animals, by the Knee-Bend and CatWalk tests, before and after TLR4-A1 or vehicle administration, at several time-points. Animals were sacrificed 28 days after OA induction. L3-L5 Dorsal Root Ganglia (DRG) were used for immunohistochemistry for TLR4 and ATF-3, spinal cords were immunoreacted for TLR4 and knee joints were processed for histopathological evaluation.

Results Antagonism by TLR4-A1 significantly reduced the nociceptive behavior of OA animals both in the Knee-Bend and Catwalk tests. The effect was immediately observed 1 day after TLR4-A1 administration, but became more evident 4 days later, maintaining thereafter. No improvement in the cartilage histology was observed. The increased ATF-3 expression observed in DRG of OA animals was significantly reduced by TLR4-A1. On the contrary, TLR4 expression slightly increased after antagonist administration both at DRG and superficial dorsal horn levels.

Conclusions Chronic treatment with TLR4-A1 showed an antinociceptive effect on OA animals, not related to articular histopathological improvement, possibly through an ATF-3 dependent mechanism.


  1. Piazza M, Rossini C, Fiorentina SD, Pozzi C, Cornelli F, Bettoni I, Fusi P, Costa B and Peri F. Glycolipids and Benzylammonium Lipids as Novel Antisepsis Agents: Synthesis and Biological Characterization. J Med Chem 2009, 52, 1209–1213.


Acknowledgements Granted by FEDER funds through COMPETE – Programa Operacional Factores de Competitividade (FCOMP-01–0124-FEDER-021359) and by National Funds through FCT – Fundação para a Ciência e a Tecnologia (PTDC/SAU-NSC/119986/2010); and by Ministerio de Economia y Competitividad (SAF2012–40075-C02–02).

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.